These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 8854098)

  • 21. Inhibition of HIV-1 Tat-mediated transactivation by quinacrine and chloroquine.
    Jiang MC; Lin JK; Chen SS
    Biochem Biophys Res Commun; 1996 Sep; 226(1):1-7. PubMed ID: 8806583
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High level inhibition of HIV replication with combination RNA decoys expressed from an HIV-Tat inducible vector.
    Fraisier C; Irvine A; Wrighton C; Craig R; Dzierzak E
    Gene Ther; 1998 Dec; 5(12):1665-76. PubMed ID: 10023446
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutation of the major 5' splice site renders a CMV-driven HIV-1 proviral clone Tat-dependent: connections between transcription and splicing.
    Bohne J; Kräusslich HG
    FEBS Lett; 2004 Apr; 563(1-3):113-8. PubMed ID: 15063733
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Histone-mediated transfer and expression of the HIV-1 tat gene in Jurkat cells.
    Demirhan I; Hasselmayer O; Chandra A; Ehemann M; Chandra P
    J Hum Virol; 1998; 1(7):430-40. PubMed ID: 10195264
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A protein phosphatase from human T cells augments tat transactivation of the human immunodeficiency virus type 1 long-terminal repeat.
    Bharucha DC; Zhou M; Nekhai S; Brady JN; Shukla RR; Kumar A
    Virology; 2002 Apr; 296(1):6-16. PubMed ID: 12036313
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transactivation of human immunodeficiency virus-1 in T-cells by Mycobacterium tuberculosis-infected mononuclear phagocytes.
    Toossi Z; Wu M; Islam N; Teixeira-Johnson L; Hejal R; Aung H
    J Lab Clin Med; 2004 Aug; 144(2):108-15. PubMed ID: 15322505
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antitat gene therapy: a candidate for late-stage AIDS patients.
    Lisziewicz J; Sun D; Lisziewicz A; Gallo RC
    Gene Ther; 1995 May; 2(3):218-22. PubMed ID: 7614253
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human immunodeficiency virus type-1 tat enhances interleukin-2 promoter activity through synergism with phorbol ester and calcium-mediated activation of the NF-AT cis-regulatory motif.
    Vacca A; Farina M; Maroder M; Alesse E; Screpanti I; Frati L; Gulino A
    Biochem Biophys Res Commun; 1994 Nov; 205(1):467-74. PubMed ID: 7999066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of human immunodeficiency virus type 1 gene expression by clade-specific Tat proteins.
    Desfosses Y; Solis M; Sun Q; Grandvaux N; Van Lint C; Burny A; Gatignol A; Wainberg MA; Lin R; Hiscott J
    J Virol; 2005 Jul; 79(14):9180-91. PubMed ID: 15994812
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stimulation of Tat-associated kinase-independent transcriptional elongation from the human immunodeficiency virus type-1 long terminal repeat by a cellular enhancer.
    West MJ; Karn J
    EMBO J; 1999 Mar; 18(5):1378-86. PubMed ID: 10064603
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An autocrine loop of HIV type-1 Tat protein responsible for the improved survival/proliferation capacity of permanently Tat-transfected cells and required for optimal HIV-1 LTR transactivating activity.
    Zauli G; La Placa M; Vignoli M; Re MC; Gibellini D; Furlini G; Milani D; Marchisio M; Mazzoni M; Capitani S
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Nov; 10(3):306-16. PubMed ID: 7552492
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HIV-1 tat transcriptional activity is regulated by acetylation.
    Kiernan RE; Vanhulle C; Schiltz L; Adam E; Xiao H; Maudoux F; Calomme C; Burny A; Nakatani Y; Jeang KT; Benkirane M; Van Lint C
    EMBO J; 1999 Nov; 18(21):6106-18. PubMed ID: 10545121
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular characterization of tat gene and long terminal repeat region of human immunodeficiency virus type-1 detected among the injecting drug users (IDUs) of Manipur, India: identification of BC recombinants.
    Mullick R; Sengupta S; Sarkar K; Chakrabarti S
    Virus Res; 2010 Feb; 147(2):195-201. PubMed ID: 19896991
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms of transcriptional transactivation and restriction of human immunodeficiency virus type I replication in an astrocytic glial cell.
    Niikura M; Dornadula G; Zhang H; Mukhtar M; Lingxun D; Khalili K; Bagasra O; Pomerantz RJ
    Oncogene; 1996 Jul; 13(2):313-22. PubMed ID: 8710370
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HIV-1 regulatory protein tat induces RNA binding proteins in central nervous system cells that associate with the viral trans-acting-response regulatory motif.
    Kundu M; Ansari SA; Chepenik LG; Pomerantz RJ; Khalili K; Rappaport J; Amini S
    J Hum Virol; 1999; 2(2):72-80. PubMed ID: 10225209
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The HLA class II transcriptional activator blocks the function of HIV-1 Tat and inhibits viral replication.
    Accolla RS; Mazza S; De Lerma Barbaro A; De Maria A; Tosi G
    Eur J Immunol; 2002 Oct; 32(10):2783-91. PubMed ID: 12355430
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transactivation of human immunodeficiency virus by herpesviruses.
    Rando RF; Pellett PE; Luciw PA; Bohan CA; Srinivasan A
    Oncogene; 1987 Mar; 1(1):13-8. PubMed ID: 2830574
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HIV-1 gp120/160 expressing cells upregulate HIV-1 LTR directed gene expression in a cell line transfected with HIV-1 LTR-reporter gene constructs.
    Merzouki A; Patel P; Cassol S; Ennaji M; Tailor P; Turcotte FR; O'Shaughnessy M; Arella M
    Cell Mol Biol (Noisy-le-grand); 1995 May; 41(3):445-52. PubMed ID: 7580840
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiple modes of transcriptional regulation by the HIV-1 Tat transactivator.
    Marcello A; Zoppé M; Giacca M
    IUBMB Life; 2001 Mar; 51(3):175-81. PubMed ID: 11547919
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activity of human immunodeficiency virus type 1 promoter/TAR regions and tat1 genes derived from individuals with different rates of disease progression.
    Kirchhoff F; Greenough TC; Hamacher M; Sullivan JL; Desrosiers RC
    Virology; 1997 Jun; 232(2):319-31. PubMed ID: 9191845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.